In the past three years, "right-to-try" advocates in 33 states have helped enact legislation to eliminate legal obstacles blocking terminally ill patients from treatments that aren't yet approved by the Food and Drug Administration. Advocates are showing considerable momentum in the remaining 17 states, potentially upending the established order for experimental drugs.